COVID vaccines and blood clots: five key questions

leave a comment »

It has been a difficult week for two COVID-19 vaccines. On 13 April, US regulators urged health-care providers to temporarily stop using a vaccine made by Johnson & Johnson (J&J) of New Brunswick, New Jersey, because of six suspected cases of unusual blood clotting among nearly seven million vaccine recipients. The move came after European regulators expressed concerns about a possible link between rare blood clots and the Oxford–AstraZeneca vaccine, developed in the United Kingdom by AstraZeneca in Cambridge and the University of Oxford …. Read more at

Written by physicsgg

April 24, 2021 at 11:49 am

Posted in Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: